Young James F's Form 4 filing
Novavax Inc (NVAX) · filed Apr 4, 2022
- Accession no.
- 0001209191-22-022544
- Filed
- Apr 4, 2022
- Trade date
- Mar 31, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $919.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Young James FCIK 0001219864 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Common Stock | SSaleDisposed | −8,945 | $73.29 | −$655,579.05 | 66,145 | Direct | |
| Mar 31, 2022 | Common Stock | SSaleDisposed | −3,255 | $74.25 | −$241,683.75 | 62,890 | Direct | |
| Mar 31, 2022 | Common Stock | SSaleDisposed | −300 | $75.10 | −$22,530 | 62,590 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.